Literature DB >> 25230084

Portal hypertension: pathophysiology, diagnosis and management.

S Bloom1, W Kemp, J Lubel.   

Abstract

Portal hypertension is an important complication of liver disease. As a result of elevated pressures within the portal vein several complications can arise, including the development of oesophageal and gastric varices, ascites, hepatic encephalopathy as well as complications secondary to circulatory dysfunction, such as hepatorenal syndrome, portopulmonary syndrome and hepatopulmonary syndrome. This review outlines the pathogenesis and diagnosis of portal hypertension and outlines the management of these various important clinical sequelae. The management of oesophageal and gastric varices is particularly important, and both the emergency management together with prophylactic management of this condition are described.
© 2014 Royal Australasian College of Physicians.

Entities:  

Keywords:  ascites; cirrhosis; encephalopathy; portal hypertension; varices

Mesh:

Year:  2015        PMID: 25230084     DOI: 10.1111/imj.12590

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  19 in total

1.  Stomal varices: a cause for intermittent haematuria post-radical cystectomy.

Authors:  Su-Min Lee; Kishoj Yogan; Thomas Carr
Journal:  BMJ Case Rep       Date:  2016-01-13

2.  A novel liver-targeted nitric oxide donor UDCA-Thr-NO protects against cirrhosis and portal hypertension.

Authors:  Jialin Sun; Menghua Li; Shiyong Fan; Zhongwu Guo; Bohua Zhong; Xueyuan Jin; Weiguo Shi
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

Review 3.  Congenital heart disease-associated liver disease: a narrative review.

Authors:  Florian P Reiter; Nino J Hadjamu; Nicole Nagdyman; Reinhart Zachoval; Julia Mayerle; Enrico N De Toni; Harald Kaemmerer; Gerald Denk
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 4.  4D Flow MRI in the portal venous system: imaging and analysis methods, and clinical applications.

Authors:  Ryota Hyodo; Yasuo Takehara; Shinji Naganawa
Journal:  Radiol Med       Date:  2022-09-19       Impact factor: 6.313

5.  Diagnostic performance of quantitative magnetic resonance imaging biomarkers for predicting portal hypertension in children and young adults with autoimmune liver disease.

Authors:  Jonathan R Dillman; Suraj D Serai; Andrew T Trout; Ruchi Singh; Jean A Tkach; Amy E Taylor; Burns C Blaxall; Lin Fei; Alexander G Miethke
Journal:  Pediatr Radiol       Date:  2019-01-03

Review 6.  Statins for treatment of chronic liver disease.

Authors:  Mohamad Kareem Marrache; Don C Rockey
Journal:  Curr Opin Gastroenterol       Date:  2021-05-01       Impact factor: 3.287

7.  MicroRNA-155 is upregulated in ascites in patients with spontaneous bacterial peritonitis.

Authors:  Philipp Lutz; Mohamed M Haimid; Alessandra Pohlmann; Jennifer Lehmann; Christian Jansen; Robert Schierwagen; Sabine Klein; Christian P Strassburg; Ulrich Spengler; Jonel Trebicka
Journal:  Sci Rep       Date:  2017-01-11       Impact factor: 4.379

8.  Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis.

Authors:  Le Wang; Yuemin Feng; Xiaowen Ma; Guangchuan Wang; Hao Wu; Xiaoyu Xie; Chunqing Zhang; Qiang Zhu
Journal:  PLoS One       Date:  2017-08-18       Impact factor: 3.240

Review 9.  The Role of Interventional Endoscopic Ultrasound in Liver Diseases: What Have We Learnt?

Authors:  Cosmas Rinaldi A Lesmana; Maria Satya Paramitha; Rino A Gani
Journal:  Can J Gastroenterol Hepatol       Date:  2021-06-28

10.  Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats.

Authors:  Jin-Hang Gao; Shi-Lei Wen; Shi Feng; Wen-Juan Yang; Yao-Yao Lu; Huan Tong; Rui Liu; Shi-Hang Tang; Zhi-Yin Huang; Ying-Mei Tang; Jin-Hui Yang; Hui-Qi Xie; Cheng-Wei Tang
Journal:  Angiogenesis       Date:  2016-07-05       Impact factor: 10.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.